PunchNew tools can detect deepfakes with 99% accuracy — PoliceThe Jerusalem PostCairo in talks with Tripoli over Turkish maritime boundary deal, Egyptian FM saysBollywood HungamaNitish Bharadwaj withdraws praise for Ramayana Part 1; says he is “deeply upset and disappointed” with Ranbir Kapoor starrerSky TG24Allarme bomba nelle scuole, Valditara: “Rischio inesistente”. Meloni convoca riunioneInquirerDOH: 7 in 10 Filipino deaths due to noncommunicable diseasesZDF heuteEntdecken Sie das ZDF-NachrichtenstudioColliderPrime Video’s Star Wars Replacement Is Hailed as the Best Space Show of All TimeDaily MaverickWHAT’S COOKING: A hunk of beef braaied on the coals, served with chimichurriFootball ItaliaCarlos Augusto wants €5m-a-year Inter deal as renewal talks stallFrance 24UNICEF head Catherine Russell: 'We're all committed to the importance of children'South China Morning Post30 Japanese porn stars denied entry into Hong Kong, forcing adult expo’s cancellationBBC BusinessWhat are cold weather payments and who can get them?
KioskNews
The Daily Newsstand · Free, Always
Wednesday, November 11, 2026
Language
La Jornada·Mexico·

Autoriza la Ssa uso de polémico fármaco contra diabetes tipo 2

Translate

El Consejo de Salubridad General de la Secretaría de Salud (Ssa) publicó ayer en el Diario Oficial de la Federación la actualización del Compendio Nacional de Insumos para la Salud 2025, en el que incluye nuevos medicamentos para tratar la diabetes tipo 2, como la semaglutida (pr

Read the full article on La Jornada →

KioskNews shows the publisher’s own headline, image, and summary — the full article always lives on their site, not ours.